PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SYK vs. EW
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SYK and EW is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.4

Performance

SYK vs. EW - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Stryker Corporation (SYK) and Edwards Lifesciences Corporation (EW). The values are adjusted to include any dividend payments, if applicable.

-30.00%-20.00%-10.00%0.00%10.00%20.00%AugustSeptemberOctoberNovemberDecember2025
12.97%
-19.33%
SYK
EW

Key characteristics

Sharpe Ratio

SYK:

1.22

EW:

-0.13

Sortino Ratio

SYK:

1.82

EW:

0.12

Omega Ratio

SYK:

1.22

EW:

1.02

Calmar Ratio

SYK:

1.99

EW:

-0.10

Martin Ratio

SYK:

4.90

EW:

-0.27

Ulcer Index

SYK:

4.76%

EW:

20.11%

Daily Std Dev

SYK:

19.15%

EW:

41.50%

Max Drawdown

SYK:

-58.63%

EW:

-54.32%

Current Drawdown

SYK:

-2.00%

EW:

-46.60%

Fundamentals

Market Cap

SYK:

$146.17B

EW:

$41.16B

EPS

SYK:

$9.36

EW:

$2.59

PE Ratio

SYK:

40.96

EW:

26.94

PEG Ratio

SYK:

2.68

EW:

6.42

Total Revenue (TTM)

SYK:

$16.16B

EW:

$4.34B

Gross Profit (TTM)

SYK:

$10.03B

EW:

$3.39B

EBITDA (TTM)

SYK:

$3.89B

EW:

$1.24B

Returns By Period

In the year-to-date period, SYK achieves a 6.49% return, which is significantly higher than EW's -5.74% return. Over the past 10 years, SYK has outperformed EW with an annualized return of 16.79%, while EW has yielded a comparatively lower 12.57% annualized return.


SYK

YTD

6.49%

1M

7.00%

6M

12.97%

1Y

22.95%

5Y*

13.84%

10Y*

16.79%

EW

YTD

-5.74%

1M

-4.16%

6M

-19.33%

1Y

-6.26%

5Y*

-2.59%

10Y*

12.57%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SYK vs. EW — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SYK
The Risk-Adjusted Performance Rank of SYK is 8181
Overall Rank
The Sharpe Ratio Rank of SYK is 8383
Sharpe Ratio Rank
The Sortino Ratio Rank of SYK is 7878
Sortino Ratio Rank
The Omega Ratio Rank of SYK is 7474
Omega Ratio Rank
The Calmar Ratio Rank of SYK is 9090
Calmar Ratio Rank
The Martin Ratio Rank of SYK is 8181
Martin Ratio Rank

EW
The Risk-Adjusted Performance Rank of EW is 3939
Overall Rank
The Sharpe Ratio Rank of EW is 3939
Sharpe Ratio Rank
The Sortino Ratio Rank of EW is 3636
Sortino Ratio Rank
The Omega Ratio Rank of EW is 3838
Omega Ratio Rank
The Calmar Ratio Rank of EW is 4040
Calmar Ratio Rank
The Martin Ratio Rank of EW is 4141
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SYK vs. EW - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Stryker Corporation (SYK) and Edwards Lifesciences Corporation (EW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SYK, currently valued at 1.22, compared to the broader market-2.000.002.004.001.22-0.13
The chart of Sortino ratio for SYK, currently valued at 1.82, compared to the broader market-4.00-2.000.002.004.006.001.820.12
The chart of Omega ratio for SYK, currently valued at 1.22, compared to the broader market0.501.001.502.001.221.02
The chart of Calmar ratio for SYK, currently valued at 1.99, compared to the broader market0.002.004.006.001.99-0.10
The chart of Martin ratio for SYK, currently valued at 4.90, compared to the broader market-10.000.0010.0020.0030.004.90-0.27
SYK
EW

The current SYK Sharpe Ratio is 1.22, which is higher than the EW Sharpe Ratio of -0.13. The chart below compares the historical Sharpe Ratios of SYK and EW, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.002.50AugustSeptemberOctoberNovemberDecember2025
1.22
-0.13
SYK
EW

Dividends

SYK vs. EW - Dividend Comparison

SYK's dividend yield for the trailing twelve months is around 0.85%, while EW has not paid dividends to shareholders.


TTM20242023202220212020201920182017201620152014
SYK
Stryker Corporation
0.85%0.90%1.02%1.16%0.97%0.96%1.02%1.23%1.13%1.31%1.52%1.34%
EW
Edwards Lifesciences Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

SYK vs. EW - Drawdown Comparison

The maximum SYK drawdown since its inception was -58.63%, which is greater than EW's maximum drawdown of -54.32%. Use the drawdown chart below to compare losses from any high point for SYK and EW. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-2.00%
-46.60%
SYK
EW

Volatility

SYK vs. EW - Volatility Comparison

Stryker Corporation (SYK) has a higher volatility of 6.92% compared to Edwards Lifesciences Corporation (EW) at 5.71%. This indicates that SYK's price experiences larger fluctuations and is considered to be riskier than EW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%AugustSeptemberOctoberNovemberDecember2025
6.92%
5.71%
SYK
EW

Financials

SYK vs. EW - Financials Comparison

This section allows you to compare key financial metrics between Stryker Corporation and Edwards Lifesciences Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab